NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

TSBX

Turnstone Biologics Corp

Jul 03 • 03:11PM ET

0.3618

Dollar change +0.0017
Percentage change 0.47	%

Healthcare • Biotechnology • USA • NASD

Peers: BNTX VRTX MRNA CRSP NTLA EDIT SGMO FATE ONCT CYCN

| Held by: VXF VTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.73	Insider Own	25.54%	Shs Outstand	23.14M	Perf Week	8.88%
Market Cap	8.37M	Forward P/E	-	EPS next Y	-0.51	Insider Trans	0.00%	Shs Float	17.23M	Perf Month	4.51%
Enterprise Value	-12.90M	PEG	-	EPS next Q	-0.16	Inst Own	22.75%	Short Float	2.50%	Perf Quarter	-4.74%
Income	-63.01M	P/S	-	EPS this Y	77.52%	Inst Trans	-3.55%	Short Ratio	1.13	Perf Half Y	-27.64%
Sales	0.00M	P/B	0.42	EPS next Y	26.09%	ROA	-103.30%	Short Interest	0.43M	Perf YTD	-27.19%
Book/sh	0.86	P/C	0.38	EPS next 5Y	-	ROE	-126.03%	52W High	2.69 -86.55%	Perf Year	-86.35%
Cash/sh	0.95	P/FCF	-	EPS past 3/5Y	- -	ROIC	-315.29%	52W Low	0.29 24.76%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.28% 8.47%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	16.34%	Oper. Margin	-	ATR (14)	0.03	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.70	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	52.31	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.70	EPS Q/Q	40.19%	SMA20	0.92%	Beta	1.33	Target Price	1.00
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	4.24%	Rel Volume	0.11	Prev Close	0.36
Employees	14	LT Debt/Eq	0.00	Earnings	May 08 AMC	SMA200	-16.53%	Avg Volume	381.60K	Price	0.36
IPO	Jul 21, 2023	Option/Short	No / Yes	EPS/Sales Surpr.	-96.15% -	Trades		Volume	41,587	Change	0.47%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-05-25	Downgrade	Piper Sandler	Overweight → Neutral	$3.75 → $0.40
Nov-15-24	Downgrade	BofA Securities	Neutral → Underperform
Oct-14-24	Downgrade	BofA Securities	Buy → Neutral
Aug-16-23	Initiated	SVB Securities	Market Perform
Aug-15-23	Initiated	Piper Sandler	Overweight	$20
Aug-15-23	Initiated	BofA Securities	Buy	$18

Jun-27-25 07:30AM	Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right (GlobeNewswire) +6.14%
May-08-25 06:00PM	Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights (GlobeNewswire) +5.29%
Mar-28-25 09:03PM	Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-07-25 12:00PM	Turnstone Biologics Corp. (TSBX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) -6.78%
Feb-05-25 06:28AM	Amgen obesity drug on hold; Regeneron sets first dividend (BioPharma Dive) +7.02%
09:00AM	Loading…
Feb-04-25 09:00AM	Turnstone Biologics Announces Plans to Explore Strategic Alternatives (GlobeNewswire) +11.28%
Nov-12-24 04:05PM	Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights (GlobeNewswire) +10.92% -7.75%
Nov-05-24 09:01AM	Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
Oct-12-24 06:47AM	Turnstone Biologics Streamlines Operations and Leadership (TipRanks)
Oct-11-24 06:36AM	FDA clears Roche breast cancer drug; Turnstone lays off 60% of staff (BioPharma Dive)
06:00AM	Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway (GlobeNewswire)
Aug-14-24 09:54PM	TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024 (InvestorPlace) -61.93%
04:05PM	Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights (GlobeNewswire)
04:01PM	Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer (GlobeNewswire)
Aug-12-24 05:49PM	Turnstone Biologics Corp. (TSBX): This Penny Stock is a Strong Buy According to Analysts (Insider Monkey)
09:53PM	Loading…
May-13-24 09:53PM	TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024 (InvestorPlace) -5.28%
05:01PM	Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights (GlobeNewswire)
May-08-24 09:00AM	Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference (GlobeNewswire)
Apr-16-24 09:00AM	Turnstone Biologics Appoints William Waddill to its Board of Directors (GlobeNewswire)
Mar-22-24 07:52AM	TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023 (InvestorPlace) -10.48%
Mar-21-24 05:06PM	Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights (GlobeNewswire) +8.44%
Feb-21-24 06:00AM	Turnstone Biologics to Participate in Upcoming Investor Conferences (GlobeNewswire) +7.49%
Feb-20-24 05:00PM	Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq. (GlobeNewswire) -11.67%
Nov-27-23 06:00AM	Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-09-23 09:49PM	Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights (GlobeNewswire) -11.94%
Nov-03-23 06:00AM	Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
Oct-30-23 06:00AM	Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber (GlobeNewswire) +24.12%
Sep-28-23 06:00AM	Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting (GlobeNewswire) +10.36%
Sep-01-23 05:57PM	Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +10.47% -11.83%
Aug-14-23 08:41PM	Steven Cohen's Q2 2023 13F Filing Update: Top Trades and Portfolio Overview (GuruFocus.com)
06:30PM	Loading…
Aug-04-23 06:30PM	Apogee Therapeutics, Turnstone Biologics, and More Stocks See Action From Activist Investors (Barrons.com) -5.67%
Jul-27-23 07:01PM	Steven Cohen Acquires Stake in Turnstone Biologics Corp (GuruFocus.com)
05:36PM	FMR LLC Acquires Significant Stake in Turnstone Biologics Corp (GuruFocus.com)
Jul-21-23 02:15AM	Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)

Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It engages in the business of developing and commercializing therapeutics. The company is focused on developing new medicines to treat and cure patients with solid tumors. Turnstone Biologics was founded in 2015 and is headquartered in La Jolla, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TSBX

Turnstone Biologics Corp

Upgrade your FINVIZ experience